| Product Code: ETC12702626 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Nuclear Medicines Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Nuclear Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Nuclear Medicines Market - Industry Life Cycle |
3.4 Poland Nuclear Medicines Market - Porter's Five Forces |
3.5 Poland Nuclear Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Poland Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.7 Poland Nuclear Medicines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Poland Nuclear Medicines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Poland Nuclear Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases leading to higher demand for nuclear medicines |
4.2.2 Technological advancements in nuclear medicine imaging and therapy |
4.2.3 Rising investments in healthcare infrastructure and RD activities in Poland |
4.3 Market Restraints |
4.3.1 High costs associated with the development and production of nuclear medicines |
4.3.2 Stringent regulatory requirements for the approval and usage of nuclear medicines in Poland |
5 Poland Nuclear Medicines Market Trends |
6 Poland Nuclear Medicines Market, By Types |
6.1 Poland Nuclear Medicines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Nuclear Medicines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Poland Nuclear Medicines Market Revenues & Volume, By Diagnostic Radiopharmaceuticals, 2021 - 2031F |
6.1.4 Poland Nuclear Medicines Market Revenues & Volume, By Therapeutic Radiopharmaceuticals, 2021 - 2031F |
6.2 Poland Nuclear Medicines Market, By Application Area |
6.2.1 Overview and Analysis |
6.2.2 Poland Nuclear Medicines Market Revenues & Volume, By Oncology Imaging, 2021 - 2031F |
6.2.3 Poland Nuclear Medicines Market Revenues & Volume, By Thyroid Treatment, 2021 - 2031F |
6.2.4 Poland Nuclear Medicines Market Revenues & Volume, By Cardiac Imaging, 2021 - 2031F |
6.2.5 Poland Nuclear Medicines Market Revenues & Volume, By Bone Pain Palliation, 2021 - 2031F |
6.3 Poland Nuclear Medicines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Poland Nuclear Medicines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Poland Nuclear Medicines Market Revenues & Volume, By Endocrinology Clinics, 2021 - 2031F |
6.3.4 Poland Nuclear Medicines Market Revenues & Volume, By Cardiology Centers, 2021 - 2031F |
6.3.5 Poland Nuclear Medicines Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.4 Poland Nuclear Medicines Market, By Product Type |
6.4.1 Overview and Analysis |
6.4.2 Poland Nuclear Medicines Market Revenues & Volume, By Technetium-99m, 2021 - 2031F |
6.4.3 Poland Nuclear Medicines Market Revenues & Volume, By Iodine-131, 2021 - 2031F |
6.4.4 Poland Nuclear Medicines Market Revenues & Volume, By Thallium-201, 2021 - 2031F |
6.4.5 Poland Nuclear Medicines Market Revenues & Volume, By Samarium-153, 2021 - 2031F |
7 Poland Nuclear Medicines Market Import-Export Trade Statistics |
7.1 Poland Nuclear Medicines Market Export to Major Countries |
7.2 Poland Nuclear Medicines Market Imports from Major Countries |
8 Poland Nuclear Medicines Market Key Performance Indicators |
8.1 Number of new nuclear medicine applications approved by regulatory authorities |
8.2 Investment in research and development of new nuclear medicine technologies |
8.3 Adoption rate of nuclear medicine imaging and therapy techniques in the healthcare sector in Poland |
9 Poland Nuclear Medicines Market - Opportunity Assessment |
9.1 Poland Nuclear Medicines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Poland Nuclear Medicines Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.3 Poland Nuclear Medicines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Poland Nuclear Medicines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 Poland Nuclear Medicines Market - Competitive Landscape |
10.1 Poland Nuclear Medicines Market Revenue Share, By Companies, 2024 |
10.2 Poland Nuclear Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here